The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

It’s hard to know exactly what change in Washington will mean for the health care industry starting next year. But we have ...

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

The pharmaceutical industry is poised for an opportunity to tweak parts of the Medicare drug pricing negotiation law, after ...

In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

REMS programmes are typically implemented after drug approval when the FDA determines that a medication needs to be closely ...